Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching (vol 21, 10, 2022)
机构:[1]Department of Thoracic Oncology, Affiliated Hospital, Guizhou Medical University, Guiyang, Guizhou, China[2]Teaching and Research Section of Oncology, Guizhou Medical University, Guiyang, Guizhou, China[3]The Fourth People's Hospital of Guiyang, Guiyang, China[4]Sichuan Cancer Hospital and Institute, Sichuan四川省肿瘤医院[5]The First Clinical Medical College of Lanzhou University, Gansu Provincial Cancer Hospital[6]Affiliated Cancer Hospital of Guizhou Medical University, Guizhou, China
第一作者机构:[1]Department of Thoracic Oncology, Affiliated Hospital, Guizhou Medical University, Guiyang, Guizhou, China[2]Teaching and Research Section of Oncology, Guizhou Medical University, Guiyang, Guizhou, China[3]The Fourth People's Hospital of Guiyang, Guiyang, China
通讯作者:
通讯机构:[1]Department of Thoracic Oncology, Affiliated Hospital, Guizhou Medical University, Guiyang, Guizhou, China[6]Affiliated Cancer Hospital of Guizhou Medical University, Guizhou, China
推荐引用方式(GB/T 7714):
Liu Jie,Li Tao,Wang Xiaohu,et al.Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching (vol 21, 10, 2022)[J].TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH.2023,22(11):2415-2415.doi:10.4314/tjpr.v22i11.23.
APA:
Liu, Jie,Li, Tao,Wang, Xiaohu,Su, Shengfa,Li, Qingsong...&Lu, Bing.(2023).Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching (vol 21, 10, 2022).TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH,22,(11)
MLA:
Liu, Jie,et al."Volumetric-modulated arc therapy as an alternative to intensity-modulated radiotherapy for primary tumors of advanced non-small-cell lung cancer: A multicenter retrospective analysis based on propensity score matching (vol 21, 10, 2022)".TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH 22..11(2023):2415-2415